Xponance Inc. Sells 116 Shares of Teleflex Incorporated (NYSE:TFX)

Xponance Inc. lowered its position in shares of Teleflex Incorporated (NYSE:TFX) by 1.8% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,355 shares of the medical technology company’s stock after selling 116 shares during the period. Xponance Inc.’s holdings in Teleflex were worth $1,337,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently made changes to their positions in TFX. Vanguard Group Inc. grew its position in Teleflex by 1.8% during the first quarter. Vanguard Group Inc. now owns 5,550,727 shares of the medical technology company’s stock worth $1,255,408,000 after buying an additional 96,711 shares in the last quarter. Janus Henderson Group PLC grew its position in Teleflex by 12.0% during the first quarter. Janus Henderson Group PLC now owns 5,409,317 shares of the medical technology company’s stock worth $1,223,424,000 after buying an additional 581,312 shares in the last quarter. Wellington Management Group LLP grew its position in Teleflex by 2.1% during the fourth quarter. Wellington Management Group LLP now owns 2,496,566 shares of the medical technology company’s stock worth $622,494,000 after buying an additional 52,533 shares in the last quarter. Cooke & Bieler LP grew its position in Teleflex by 23.3% during the second quarter. Cooke & Bieler LP now owns 912,797 shares of the medical technology company’s stock worth $191,989,000 after buying an additional 172,335 shares in the last quarter. Finally, TD Asset Management Inc grew its position in Teleflex by 12.0% during the second quarter. TD Asset Management Inc now owns 456,081 shares of the medical technology company’s stock worth $95,928,000 after buying an additional 48,832 shares in the last quarter. Institutional investors own 95.62% of the company’s stock.

Insider Transactions at Teleflex

In related news, Director Stuart A. Randle sold 2,674 shares of the business’s stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $238.93, for a total value of $638,898.82. Following the completion of the sale, the director now directly owns 5,496 shares of the company’s stock, valued at approximately $1,313,159.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.43% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the company. Truist Financial increased their price target on Teleflex from $240.00 to $247.00 and gave the stock a “hold” rating in a research report on Monday, August 5th. Stephens increased their price target on Teleflex from $275.00 to $290.00 and gave the stock an “overweight” rating in a research report on Friday, August 2nd. Piper Sandler raised Teleflex from a “neutral” rating to an “overweight” rating and raised their target price for the company from $205.00 to $245.00 in a report on Monday, July 1st. Finally, Royal Bank of Canada raised their target price on Teleflex from $235.00 to $260.00 and gave the company an “outperform” rating in a report on Friday, August 2nd. Three research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $265.57.

Teleflex Trading Up 0.8 %

NYSE TFX opened at $246.83 on Friday. The company has a market cap of $11.63 billion, a price-to-earnings ratio of 39.62, a price-to-earnings-growth ratio of 2.23 and a beta of 1.16. The company has a quick ratio of 1.44, a current ratio of 2.58 and a debt-to-equity ratio of 0.36. Teleflex Incorporated has a twelve month low of $177.63 and a twelve month high of $257.85. The business’s fifty day moving average is $236.98 and its 200 day moving average is $221.08.

Teleflex (NYSE:TFX) last announced its earnings results on Thursday, August 1st. The medical technology company reported $3.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.33 by $0.09. The business had revenue of $749.70 million during the quarter, compared to analyst estimates of $762.98 million. Teleflex had a return on equity of 14.51% and a net margin of 8.76%. Teleflex’s revenue for the quarter was up .9% compared to the same quarter last year. During the same period last year, the company earned $3.41 EPS. As a group, sell-side analysts expect that Teleflex Incorporated will post 13.97 EPS for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 16th. Stockholders of record on Thursday, August 15th were given a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.55%. The ex-dividend date was Thursday, August 15th. Teleflex’s dividend payout ratio (DPR) is presently 21.83%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.